[1] P. Kleihues, P.C. Burger, B.W. Scheithauer, Histological
Typing of Tumours of the Central Nervous System. World [17]
Health Organization International Histological Classification
of Tumours, 2nd Edition, Springer-Verlag, Berlin, 1993.
[2] J.S. Smith, A. Perry, T.J. Borell, H.K. Lee, J. O'Fallon, S.M.
Hosek, D. Kimmel, A. Yates, P.C. Burger, B.W. Scheithauer,
R.B. Jenkins, Alterations of chromosome arms 1p and 19q as
predictors of survival in oligodendrogliomas, astrocytomas, [18]
and mixed oligoastrocytomas, J. Clin. Oncol. 18 (2000)
636–645.
[3] J.S. Wan, S.J. Sharp, J.M.C. Poirier, P.C. Wagaman, J. Chambers, J. Pyati, Y.-L. Horn, J.E. Galindo, A. Huvar, P.A. Peterson, M.R. Jackson, M.G. Erlander, Cloning differentially
[19]
expressed mRNAs, Nat. Biotech. 14 (1997) 1685–1691.
[4] M.R. Schiller, D.N. Darlington, The stage-specific expression
of RESP18 in the testes, J. Histochem. Cytochem. 44 (1996)
[20]
1489–1496.
[5] M.R. Schiller, Genes expressed in the mouse pituitary cortico-[21]
trope AtT-20/D-16v tumor cell line, Pituitary 3 (2001) 143–
154.
[6] G. Lennon, C. Auffray, M. Polymeropoulos, M.B. Soares,
The I.M.A.G.E. Consortium: an integrated molecular analysis
[22]
of genomes and their expression, Genomics 33 (1996) 151–
152.
[7] S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z.
Zhaqng, W. Miller, D.J. Lipman, Gapped BLAST and PSIBLAST: a new generation of protein database search
[23]
programs, Nucleic Acids Res. 25 (1997) 3389–3402.
[8] J. Reifenberger, G. Reifenberger, L. Liu, C.D. James, W.
Wechsler, V.P. Collins, Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q
and 1p, Am. J. Pathol. 145 (1994) 1175–1190.
[24]
[9] M.J. Bello, J. Vaquero, J.M. de Campos, M.E. Kusak, J.L.
Sarasa, J. Saez-Castresana, A. Pestana, J.A. Rey, Molecular
analysis of chromosome 1 abnormalities in human gliomas
reveals frequent loss of 1p in oligodendroglial tumors, Int. J.
[25]
Cancer 57 (1994) 172–175.
